The role of Crim-1 in lens development and eye disease.
The role of Crim-1 in lens development and eye disease.
批准号:
nhmrc : 142977
负责人:
Prof Frank Lovicu
金额:
$13.1万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2001
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2001-01-01 至 2003-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have recently isolated a novel gene (Crim1) and shown it to be strongly expressed during eye development. Its protein structure indicates that it may act to regulate the activities of two growth factor families, the TGF superfamily and the insulin-IGFs. These growth factors effect the behaviour of many cell types that influence events in normal and pathological development. For example in the eye lens, TGF 1 can induce cataractous changes in epithelial cells and early differentiating fibres; however, TGF signalling appears to be required for events in late stages of fibre cell maturation. Cataract is the leading cause of blindness and arises when lens cell architecture is disrupted and-or proteins aggregate abnormally. In humans, following ocular trauma, eye surgery, or in association with other diseases, cataracts can develop. These cataracts feature the development of subcapsular fibrotic plaques which obscure vision. We have shown that lenses cultured in the presence of TGF can mimic production of these plaques suggesting that these cataracts result from inappropriate activation of TGF . TGF is expressed in the lens and is abundant in the ocular media that bathes the lens. Thus, it appears that complex regulation of TGF bioavailability is required; epithelial cells and young fibre cells need to be protected from its cataractogenic effects, whereas older fibres require TGF signalling for maturation and-or survival. The expression pattern of Crim1 in the lens is consistent with it having a key role in inhibiting TGF in the lens. Thus, we hypothesise that Crim1 plays important roles in the lens, possibly via the modulation of members of the TGF superfamily and insulin-IGFs. We predict that Crim1 acts to maintain the lens epithelial phenotype and facilitate events in early fibre differentiation. If so, this may have implications for devising molecular strategies for preventing or slowing diseases, such as the various forms of human cataract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preventing Blindness: Blocking TGF¤-induced EMT and Cataract Development
-
批准号:nhmrc : 1024799
-
项目类别:Project Grants
-
资助金额:$22.93万
-
财政年份:2012
-
负责人:Prof Frank Lovicu
-
依托单位:
Role of primary cilia and PCP proteins in lens development: implications for lens regeneration after cataract surgery
-
批准号:nhmrc : 1003356
-
项目类别:NHMRC Project Grants
-
资助金额:$27.59万
-
财政年份:2011
-
负责人:Prof Frank Lovicu
-
依托单位:
Roles for MAPK-ERK1-2, -catenin-TCF and Smad3 mediated signalling pathways in TGF -induced cataract
-
批准号:nhmrc : 512355
-
项目类别:NHMRC Project Grants
-
资助金额:$22.61万
-
财政年份:2008
-
负责人:Prof Frank Lovicu
-
依托单位:
Regulation of lens cell behaviour by RTK antagonists, Sef and Sprouty.
-
批准号:nhmrc : 457336
-
项目类别:NHMRC Project Grants
-
资助金额:$21.3万
-
财政年份:2007
-
负责人:Prof Frank Lovicu
-
依托单位:
Growth-factor induced signalling pathways involved in the regulation of lens cell behaviour
-
批准号:nhmrc : 301939
-
项目类别:NHMRC Project Grants
-
资助金额:$16.9万
-
财政年份:2004
-
负责人:Prof Frank Lovicu
-
依托单位:
Inductive Interactions between Lens and Optic Cup Specify Cell Fates
-
批准号:nhmrc : 253669
-
项目类别:NHMRC Project Grants
-
资助金额:$17.7万
-
财政年份:2003
-
负责人:Prof Frank Lovicu
-
依托单位:
Analysis of FGF receptor signalling involved in lens cell proliferation and differentiation
-
批准号:nhmrc : 107297
-
项目类别:NHMRC Project Grants
-
资助金额:$22.87万
-
财政年份:2000
-
负责人:Prof Frank Lovicu
-
依托单位:
The role of FGF in controlling lens cell behaviour
-
批准号:nhmrc : 967127
-
项目类别:Early Career Fellowships
-
资助金额:$14.36万
-
财政年份:1996
-
负责人:Prof Frank Lovicu
-
依托单位:
国内基金
海外基金
基于新型微环DNA技术平台CRIM的H9N2禽流感广谱性原位靶向纳米疫苗激活特异性细胞免疫机制研究
-
批准号:32072897
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2020
-
负责人:姜延龙
-
依托单位:
软骨分化circ_CRIM1/circRNA_005505/miR-320c组成的ceRNA靶向Slc39a8促进软骨再生、抑制退变的作用和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:孟繁钢
-
依托单位:
Crim1通过瘤细胞FAK-ERK1/2-VEGF信号和内皮VEGFR2磷酸化双重调节宫颈鳞癌微血管生成的研究
-
批准号:81760471
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:宋恩霖
-
依托单位: